Geron (GERN) Depreciation and Depletion (2017 - 2021)
Geron (GERN) posted Depreciation and Depletion of $53000.0 for Q2 2021, up 10.42% sequentially from $48000.0 in Q1 2021, and up 60.61% YoY from $33000.0 in Q2 2020.
Geron (GERN) Depreciation and Depletion (2017 - 2021) Analysis & Trends
Geron has reported Depreciation and Depletion for 5 years, with the latest figure at $53000.0 in Q2 2021.
- Quarterly Depreciation and Depletion rose 60.61% year-over-year to $53000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $199000.0 (up 103.06% YoY) and the FY2020 annual result came in at $158000.0, up 146.88% from the prior year.
- Depreciation and Depletion improved to $53000.0 in Q2 2021 per GERN's latest filing, from $48000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $53000.0 in Q2 2021 and troughed at $9000.0 in Q3 2019.
- A 5-year average of $25444.4 and a median of $19000.0 in 2017 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2019 and 2020: Depreciation and Depletion tumbled 35.71% in 2019, then jumped 444.44% in 2020.
- Over 5 years, Depreciation and Depletion stood at $19000.0 in 2017, then declined by 26.32% to $14000.0 in 2018, then jumped by 107.14% to $29000.0 in 2019, then surged by 68.97% to $49000.0 in 2020, then advanced by 8.16% to $53000.0 in 2021.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $53000.0, $48000.0, and $49000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 53,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Dec 31, 2020 | 49,000.00 |
| Dec 31, 2020 | 49,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | 33,000.00 |
| Jun 30, 2020 | 33,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Dec 31, 2019 | 29,000.00 |
| Dec 31, 2019 | 29,000.00 |
| Sep 30, 2019 | 9,000.00 |
| Sep 30, 2019 | 9,000.00 |
| Jun 30, 2019 | 11,000.00 |
| Jun 30, 2019 | 11,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Mar 31, 2019 | 15,000.00 |